Monday, November 9, 2020
- 9:00AM-11:00AM
-
Abstract Number: 1870
Development of Candidate Criteria for Axial Disease in Juvenile Spondyloarthritis: An International Collaboration
Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: Axial SpA- 9:00AM-11:00AM
-
Abstract Number: 1877
Diagnosis of Axial Spondyloarthritis: A Primary Unmet Educational Need for Rheumatologists Is Interpretation of MRI
Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: Axial SpA- 9:00AM-11:00AM
-
Abstract Number: 1539
Diagnostic Value of Ultrasound Halo Count and Halo Score in Giant Cell Arteritis: A Retrospective Study from Routine Care
Imaging of Rheumatic Diseases Poster- 9:00AM-11:00AM
-
Abstract Number: 1874
Differences Between Men and Women in the Patient Pathways to Diagnosis of Ankylosing Spondylitis
Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: Axial SpA- 9:00AM-11:00AM
-
Abstract Number: 1787
Differences in Chromatin Architecture Between Treatment Naïve Pediatric and Adult Lupus Patients
SLE – Diagnosis, Manifestations, & Outcomes Poster III: Bench to Bedside- 9:00AM-11:00AM
-
Abstract Number: 1851
Different Disease Activity Trajectories in Early Axial Spondyloarthritis Lead to Significantly Different Long-term Outcomes : A Cluster-based Analysis of the DESIR Cohort
Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster- 9:00AM-11:00AM
-
Abstract Number: 1529
Differentially Expressed Chemokines and Cytokines in Peripheral Blood Mononuclear Cells (PBMCs) of Rheumatoid Arthritis (RA) Patients
Cytokines & Cell Trafficking Poster- 9:00AM-11:00AM
-
Abstract Number: 1884
Disease Activity in an Axial Spondyloarthritis Cohort During the COVID-19 Pandemic
Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: Axial SpA- 9:00AM-11:00AM
-
Abstract Number: 1714
Disease Activity Trajectories for Early and Established Rheumatoid Arthritis: Real World Results from a Rheumatoid Arthritis Cohort
RA – Diagnosis, Manifestations, & Outcomes Poster IV: Lifespan of a Disease- 9:00AM-11:00AM
-
Abstract Number: 1764
Disease Modifying Anti-rheumatic Drug and Biologic Therapy in Pregnancy: A Single-center Mixed Methods Study
Reproductive Issues in Rheumatic Disorders Poster- 9:00AM-11:00AM
-
Abstract Number: 1571
Distinct T Cell Responses in Inflammatory Arthritis Associated with Combined CTLA-4 and PD-1 Inhibitor Therapy
Immunological Complications of Therapy Poster- 9:00AM-11:00AM
-
Abstract Number: 1811
Distinctive Molecular Signatures Among Monocytes from Childhood- and Adult-onset Systemic Lupus Erythematosus: Clinical Involvement and Relevance of Sustained Anti-dsDNA Positivity
SLE – Diagnosis, Manifestations, & Outcomes Poster III: Bench to Bedside- 9:00AM-11:00AM
-
Abstract Number: L05
DMARD Changes for Patients with Rheumatoid Arthritis in the US During the First Three Months of the COVID-19 Pandemic
Late-Breaking Posters- 9:00AM-11:00AM
-
Abstract Number: 1907
DNASE1L3 R206C Polymorphism, a Systemic Sclerosis Risk Factor, Causes Impaired Digestion of Genomic DNA in Apoptosis-derived Extracellular Vesicles